The global neurodegenerative disease market is poised for robust growth over the next decade, with the industry expected to expand from an estimated USD 55.6 billion in 2025 to USD 109.5 billion by 2035. This marks a compound annual growth rate (CAGR) of 6.9%, underscoring the immense opportunities available for manufacturers in this rapidly evolving sector. The growth is primarily driven by the increasing prevalence of neurological disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases, alongside advancements in drug development and research.

Get a Sample Report:- https://www.futuremarketinsights.com/reports/sample/rep-gb-1052